Last $65.24 USD
Change Today +3.38 / 5.46%
Volume 5.3M
RMD On Other Exchanges
Symbol
Exchange
New York
OTC US
Frankfurt
Frankfurt
As of 8:04 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

resmed inc (RMD) Snapshot

Open
$63.99
Previous Close
$61.86
Day High
$67.50
Day Low
$63.65
52 Week High
01/23/15 - $67.50
52 Week Low
02/3/14 - $41.52
Market Cap
9.1B
Average Volume 10 Days
1.9M
EPS TTM
$2.46
Shares Outstanding
139.4M
EX-Date
02/10/15
P/E TM
26.5x
Dividend
$1.12
Dividend Yield
1.62%
Current Stock Chart for RESMED INC (RMD)

resmed inc (RMD) Related Businessweek News

No Related Businessweek News Found

resmed inc (RMD) Details

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. Its products portfolio includes airflow generators, diagnostic products, mask systems, motors, and headgear, as well as other accessories, such as cold passover humidifiers, carry bags, and breathing circuits; and humidifiers comprising H5i and H4i, which connect with the continuous and variable positive airway pressure, and AutoSet flow generators to humidify and heat the air delivered to the patient to prevent the drying of nasal passages. The company also offers data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. It has a collaboration agreement with Qualcomm Life, Inc. to develop connected health solutions based on 2net and HealthyCircles platforms. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

4,100 Employees
Last Reported Date: 08/8/14
Founded in 1989

resmed inc (RMD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $787.5K
President and Chief Operating Officer
Total Annual Compensation: $664.6K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $494.7K
President of Americas
Total Annual Compensation: $434.6K
Chief Administrative Officer, Global General ...
Total Annual Compensation: $485.7K
Compensation as of Fiscal Year 2014.

resmed inc (RMD) Key Developments

ResMed Inc. Declares Quarterly Dividend, Payable on March 19, 2015

ResMed Inc. declared a quarterly dividend of $0.28 per share, with a record date of February 12, 2015 and payable on March 19, 2015.

ResMed Inc. Reports Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2014

ResMed Inc. reported unaudited consolidated earnings results for second quarter and six months ended December 31, 2014. For the quarter, the company reported net revenue of $422,952,000 against $384,341,000 a year ago. Income from operations was $109,146,000 against $105,020,000 a year ago. Income before income tax was $115,511,000 against $109,461,000 a year ago. Net income was $91,181,000 against $86,636,000 a year ago. Diluted earnings per share were $0.64 against $0.60 a year ago. Cash flow from operations was $106.0 million. For the six months, the company’s net revenue was $803,351,000 against $742,003,000 a year ago. Income from operations was $203,821,000 against $201,903,000 a year ago. Income before income tax was $217,441,000 against $211,530,000 a year ago. Net income was $174,440,000 against $167,566,000 a year ago. Diluted earnings per share were $1.22 against $1.15 a year ago. Net cash provided by operating activities was $192,538,000 against $174,590,000 a year ago. Purchase of property, plant and equipment was $39,675,000 against $36,426,000 a year ago.

ResMed Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 08:00 AM

ResMed Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 08:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Michael J. Farrell, Chief Executive Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMD:US $65.24 USD +3.38

RMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $29.35 USD -0.165
IDEXX Laboratories Inc $167.06 USD +1.72
Mettler-Toledo International Inc $303.05 USD -1.72
Teleflex Inc $111.71 USD +0.51
Cooper Cos Inc/The $161.75 USD -2.35
View Industry Companies
 

Industry Analysis

RMD

Industry Average

Valuation RMD Industry Range
Price/Earnings 26.5x
Price/Sales 5.7x
Price/Book 5.8x
Price/Cash Flow 25.2x
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC, please visit www.resmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.